Page values for "Ultracet"
Appearance
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Tramadol / Acetaminophen |
| brand | String | Ultracet, Tramacet |
| structure | File | |
| classes | List of String, delimiter: , | |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-0000152F-QINU`"' |
| starting_dose | String | 2 tablets (75 mg tramadol / 650 mg acetaminophen) PO every 4-6 hours as needed; maximum 8 tablets/day for ≤5 days |
| preparations | String | Tramadol/acetaminophen 37.5/325 mg tablets |
| fda_max | String | 8 tablets/d (300 mg tramadol / 2600 mg acetaminophen); 5-day duration limit per label |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | 30-60 minutes |
| duration | String | 4-6 hours |
| halflife | String | Tramadol ~5-7 hours (M1 metabolite ~9 hours); acetaminophen 1-3 hours'"`UNIQ--ref-00001530-QINU`"' |
| bioavailability | String | Tramadol ~75% (oral); acetaminophen 85-98%'"`UNIQ--ref-00001531-QINU`"' |
| pregnancy | String | Avoid; neonatal opioid withdrawal documented.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Schedule IV|Schedule IV controlled substance]] in US (tramadol was reclassified from non-controlled to Schedule IV in 2014 after recognition of dependence risk) |